Dyne Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	573.61	435.45	121.63	172.15	200.83	300.85
Short-Term Investments	218.28	206.82	1.47	83.87	175.75	44.46
Cash & Short-Term Investments	791.89	642.27	123.1	256.01	376.57	345.31
Cash Growth	9.43%	421.75%	-51.92%	-32.02%	9.05%	2259.99%
Prepaid Expenses	14.38	17.01	6.28	9.58	5.44	3.77
Restricted Cash	-	-	-	-	0.38	-
Total Current Assets	806.26	659.28	129.38	265.59	382.39	349.09
Property, Plant & Equipment	45.79	30.01	33.39	38.41	40.96	1.95
Other Long-Term Assets	14.51	1.94	2.32	2.32	2.31	2.3
Total Assets	867.06	691.23	165.08	306.33	425.66	353.33
Accounts Payable	12.06	6.56	22.94	5.26	4.03	3.44
Accrued Expenses	42.75	30.85	23.44	18.22	20.74	7.48
Current Portion of Leases	5.04	4.85	4.72	4.61	3.89	-
Other Current Liabilities	-	-	-	0	0.06	0.05
Total Current Liabilities	59.85	42.26	51.1	28.09	28.72	10.97
Long-Term Debt	99.15	-	-	-	-	-
Long-Term Leases	16.28	19.14	22.7	25.87	28.74	-
Total Liabilities	175.28	61.4	73.79	53.96	57.47	10.97
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,975	1,580	723.8	649.5	596.93	421.57
Retained Earnings	-1,284	-949.93	-632.51	-396.57	-228.47	-79.18
Comprehensive Income & Other	0.5	0.01	-	-0.57	-0.27	-0.03
Total Common Equity	691.78	629.84	91.29	252.36	368.2	342.37
Shareholders' Equity	691.78	629.84	91.29	252.36	368.2	342.37
Total Liabilities & Equity	867.06	691.23	165.08	306.33	425.66	353.33
Total Debt	120.47	23.99	27.42	30.48	32.64	-
Net Cash (Debt)	671.42	618.28	95.69	225.53	343.94	345.31
Net Cash Growth	-3.92%	546.16%	-57.57%	-34.43%	-0.40%	2259.99%
Net Cash Per Share	5.74	6.57	1.60	4.34	6.76	23.99
Filing Date Shares Outstanding	142.82	113.12	81.96	56.34	51.6	51.46
Total Common Shares Outstanding	142.61	102.32	61.47	55.63	51.53	45.45
Working Capital	746.41	617.02	78.28	237.51	353.67	338.12
Book Value Per Share	4.85	6.16	1.49	4.54	7.15	7.53
Tangible Book Value	691.78	629.84	91.29	252.36	368.2	342.37
Tangible Book Value Per Share	4.85	6.16	1.49	4.54	7.15	7.53
Machinery	13.38	11.55	9.64	8.67	5.2	2.82
Construction In Progress	18.79	0.62	0.43	0.91	1.46	0.11
Leasehold Improvements	-	-	-	-	-	0.01

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q